View all blogs:
Proprietary purification process extends formulation shelf life
Pharma
Formulating generic drugs of equivalent stability, safety, bioequivalence, and dosage form as originator drugs can be a great challenge. James Humphrey, Research and Technology Specialist explores how...
Our Healthcare division becomes Croda Pharma
Pharma
Croda International Plc, the company that uses smart science to create high performance ingredients and solutions that improve lives, has today announced that its Health Care division will now become...
Croda Pharma wins prestigious “Best Supplier for COVID-19 Vaccine Development 2022” Award
Pharma
Croda, the company that uses smart science to improve lives, announces that it has been awarded winner a prestigious award for its work in supporting vaccine development. The company has been awarded...
Exclusive license for Croda to commercialise SSI’s CAF® vaccine adjuvants
Pharma
Croda International Plc, which uses smart science to improve lives, announces today that it has entered a strategic collaboration with Statens Serum Institut (“SSI”), the leading Danish Governmental...
Croda expands its high purity pharmaceutical excipients manufacturing capability
Pharma
This investment confirms Croda’s commitment to building its Life Sciences business and developing innovative pharmaceutical excipients, reinforcing Croda’s Purpose to use Smart science to improve...
Strengthening Life Sciences with the acquisition of Avanti Polar Lipids
Pharma
13 August 2020: A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.